Doctor profile · Federal record
Dr. Amy Evangelisto, MD
Rheumatology Physician (CMS: Rheumatology) · Voorhees, NJ
- NPI 1023119195
- Accepts Medicare
- MIPS 100.0 / 100 · 2023
- 29 yrs in practice
- Female
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
2301 E. Evesham Road, Bldg 800, Suite 115
Voorhees, NJ 08043
(856) 424-5005
fax (856) 424-4716
Credentials & registration
- NPI registered
- September 2006 — 20 yrs on file
- Profile last updated
- May 16, 2018
- Year of graduation
- 1997 — 29 yrs since
- Specialty taxonomy
- 207RR0500X — NUCC code
- State license (1)
- New Jersey #25MA07800100
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1023119195. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
88,432
Distinct HCPCS
10
Medicare allowed
$1,199,728
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
J3262 |
Injection, tocilizumab, 1 mg | 28,600 | 28 | $6 | |
J0717 |
Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | 19,600 | 29 | $5 | |
J1602 |
Injection, golimumab, 1 mg, for intravenous use | 17,300 | 60 | $13 | |
J0897 |
Injection, denosumab, 1 mg | 6,060 | 74 | $23 | |
J1745 |
Injection, infliximab, excludes biosimilar, 10 mg | 5,170 | 50 | $31 | |
J3111 |
Injection, romosozumab-aqqg, 1 mg | 3,990 | 13 | $10 | |
J0129 |
Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | 3,425 | 27 | $42 | |
J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 1,708 | 161 | $1 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 645 | 364 | $135 | |
96413 |
Administration of chemotherapy into vein, 1 hour or less | 300 | 164 | $145 |
In context: peer comparison
Among 10 peers in this city , average services per provider: 3,572. This provider delivers 25× the peer median.Open Payments
Industry payments received
All-time total
$161
Transactions
6
Manufacturers
3
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Janssen Biotech, Inc. | 3 | $113.15 | |
| Amgen Inc. | 2 | $31.40 | |
| ABBVIE INC. | 1 | $16.28 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
1,432
Patients
440
Total drug cost
$707,399
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Hydroxychloroquine Sulfate | Generic | 285 | 86 | $15,511 |
| Prednisone | Generic | 261 | 116 | $2,604 |
| Methotrexate (Methotrexate Sodium) | Brand | 239 | 64 | $8,129 |
| Gabapentin | Generic | 137 | 40 | $2,054 |
| Duloxetine Hcl | Generic | 106 | 32 | $2,769 |
| Meloxicam | Generic | 54 | 23 | $331 |
| Humira(Cf) Pen (Adalimumab) | Brand | 49 | 0 | $428,035 |
| Methylprednisolone | Generic | 49 | 41 | $418 |
| Tramadol Hcl | Generic | 47 | 12 | $321 |
| Celecoxib | Generic | 44 | 15 | $2,290 |
Hospital affiliations
Frequently asked questions
What is Dr. Amy Evangelisto's medical specialty?
Dr. Amy Evangelisto practices Rheumatology Physician in Voorhees, NJ.
Where does Dr. Amy Evangelisto practice?
Dr. Amy Evangelisto practices at 2301 E. Evesham Road, Voorhees, NJ 08043. Office phone: 8564245005.
What is Dr. Amy Evangelisto's NPI?
Dr. Amy Evangelisto's National Provider Identifier (NPI) is 1023119195, issued by NPPES.
Does Dr. Amy Evangelisto accept Medicare assignment?
Yes. Dr. Amy Evangelisto accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Amy Evangelisto commonly perform?
Top Medicare-reported procedures in 2023: Injection, tocilizumab, 1 mg (HCPCS J3262); Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) (HCPCS J0717); Injection, golimumab, 1 mg, for intravenous use (HCPCS J1602). Source: CMS Medicare Physician & Other Practitioners file.